Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study
Tóm tắt
Cerebral venous thrombosis (CVT) predominantly affects young to middle-aged women. Scarce data exist regarding the long-term prognosis. We examined the clinical course of patients with CVT overall and according to their age and sex. Using Danish registries, we identified all patients with a first-time primary inpatient diagnosis of CVT from 1996-2018 (N = 653; median age, 41 years; 67% women) and individuals from the general population matched for age, sex, and calendar year (N = 65 300). Patients with CVT were at an increased risk of venous thromboembolism (VTE) at other sites, ischemic stroke, major bleeding, and mortality. For both sexes, the increased risks of VTE at other sites were most prominent among younger patients (18-54 years), whereas the increased risks of ischemic stroke, major bleeding, and mortality were most prominent among older patients (≥55 years). Among young women, the 10-year risks of VTE at other sites for patients with CVT compared with members of the matched cohort were 2.2% vs 0.4% (risk difference, 1.8%; 95% confidence interval [CI], 0.0-3.6). Among older women, compared with members of the matched cohort, the 10-year risks were 12.8% vs 3.1% (risk difference, 9.7%; 95% CI, 1.6-17.9) for ischemic stroke, 11.1% vs 4.6% (risk difference, 6.5%; 95% CI, −1.0 to 14.1) for major bleeding, and 43.1% vs 26.7% (risk difference, 16.4%; 95% CI, 3.7-29.1) for all-cause mortality. The risk of myocardial infarction was not elevated. Clinicians should be aware of the importance of age and sex heterogeneity in the prognosis of CVT.
Tài liệu tham khảo
Otite, 2020, Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States, Neurology, 95, e2200, 10.1212/WNL.0000000000010598
Ferro, 2017, European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology, Eur J Neurol, 24, 1203, 10.1111/ene.13381
Søgaard, 2014, 30-year mortality after venous thromboembolism: a population-based cohort study, Circulation, 130, 829, 10.1161/CIRCULATIONAHA.114.009107
Ortel, 2020, American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism, Blood Adv, 4, 4693, 10.1182/bloodadvances.2020001830
Preter, 1996, Long-term prognosis in cerebral venous thrombosis, Stroke, 27, 243, 10.1161/01.STR.27.2.243
Ferro, 2002, Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study, Cerebrovasc Dis, 13, 272, 10.1159/000057855
Ferro, 2004, Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT), Stroke, 35, 664, 10.1161/01.STR.0000117571.76197.26
Gosk-Bierska, 2006, Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival, Neurology, 67, 814, 10.1212/01.wnl.0000233887.17638.d0
Martinelli, 2010, Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis, Circulation, 121, 2740, 10.1161/CIRCULATIONAHA.109.927046
Dentali, 2012, Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study, J Thromb Haemostasis, 10, 1297, 10.1111/j.1538-7836.2012.04774.x
Palazzo, 2017, Venous thrombotic recurrence after cerebral venous thrombosis: a long-term follow-up study, Stroke, 48, 321, 10.1161/STROKEAHA.116.015294
Aguiar de Sousa, 2017, Safety of pregnancy after cerebral venous thrombosis: results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY study, Stroke, 48, 3130, 10.1161/STROKEAHA.117.018829
Liberman, 2017, Risk of pulmonary embolism after cerebral venous thrombosis, Stroke, 48, 563, 10.1161/STROKEAHA.116.016316
Schmidt, 2019, The Danish health care system and epidemiological research: from health care contacts to database records, Clin Epidemiol, 11, 563, 10.2147/CLEP.S179083
Schmidt, 2014, The Danish Civil Registration System as a tool in epidemiology, Eur J Epidemiol, 29, 541, 10.1007/s10654-014-9930-3
Schmidt, 2015, The Danish National Patient Registry: a review of content, data quality, and research potential, Clin Epidemiol, 7, 449, 10.2147/CLEP.S91125
Pottegård, 2017, Data resource profile: the Danish National Prescription Registry, Int J Epidemiol, 46, 798
Helweg-Larsen, 2011, The Danish Register of Causes of Death, Scand J Publ Health, 39, 26, 10.1177/1403494811399958
Heide-Jørgensen, 2018, Sampling strategies for selecting general population comparison cohorts, Clin Epidemiol, 10, 1325, 10.2147/CLEP.S164456
Søgaard, 2018, Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study, Lancet Haematol, 5, e441, 10.1016/S2352-3026(18)30133-9
Schmidt, 2014, Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study, J Thromb Haemost, 12, 1207, 10.1111/jth.12604
Danish Neurological Society
. Cerebral venous thrombosis. 2020. Accessed 1 March 2022. https://neuro.dk/wordpress/nnbv/sinustrombose/.
Andersen, 2002, Multi-state models for event history analysis, Stat Methods Med Res, 11, 91, 10.1191/0962280202SM276ra
Wyss, 2013, Variable selection for propensity score models when estimating treatment effects on multiple outcomes: a simulation study, Pharmacoepidemiol Drug Saf, 22, 77, 10.1002/pds.3356
Devasagayam, 2016, Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study, Stroke, 47, 2180, 10.1161/STROKEAHA.116.013617
Coutinho, 2012, The incidence of cerebral venous thrombosis: a cross-sectional study, Stroke, 43, 3375, 10.1161/STROKEAHA.112.671453
Bousser, 2007, Cerebral venous thrombosis: an update, Lancet Neurol, 6, 162, 10.1016/S1474-4422(07)70029-7
Saposnik, 2011, Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 42, 1158, 10.1161/STR.0b013e31820a8364
Callaghan, 2014, Headaches and neuroimaging: high utilization and costs despite guidelines, JAMA Intern Med, 174, 819, 10.1001/jamainternmed.2014.173
Zuurbier, 2016, Risk of cerebral venous thrombosis in obese women, JAMA Neurol, 73, 579, 10.1001/jamaneurol.2016.0001
The Danish Health Data Authority, 2022
Silvis, 2018, Cancer and risk of cerebral venous thrombosis: a case-control study, J Thromb Haemost, 16, 90, 10.1111/jth.13903
Sørensen, 2007, Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study, Lancet, 370, 1773, 10.1016/S0140-6736(07)61745-0
Duman, 2017, A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study, J Stroke Cerebrovasc Dis, 26, 1848, 10.1016/j.jstrokecerebrovasdis.2017.04.020
Abelhad, 2021, Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer, Thromb J, 19, 37, 10.1186/s12959-021-00292-9
Ferro, 2019, Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial, JAMA Neurol, 76, 1457, 10.1001/jamaneurol.2019.2764
Yaghi, 2022, Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study, Stroke, 53, 728, 10.1161/STROKEAHA.121.037541
Sundbøll, 2016, Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study, BMJ Open, 6, e012832, 10.1136/bmjopen-2016-012832
Handley, 2020, Validation of ICD-10 codes shows intracranial venous thrombosis incidence to be higher than previously reported, Health Inf Manag, 49, 58
Martinelli, 1996, Factor V gene mutation is a risk factor for cerebral venous thrombosis, Thromb Haemost, 75, 393, 10.1055/s-0038-1650284
de Bruijn, 1998, Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis study group, BMJ, 316, 589, 10.1136/bmj.316.7131.589